Company Filing History:
Years Active: 2011-2020
Title: Innovations of Li-Tain Yeh in Uric Acid Modulation
Introduction
Li-Tain Yeh is a prominent inventor based in Irvine, California, known for his significant contributions to the field of medicinal chemistry. With a total of seven patents to his name, he has focused on developing compounds that modulate blood or serum uric acid levels, which is crucial for treating various health disorders.
Latest Patents
Among his latest patents is the invention of a 3,4-di-substituted pyridine compound, specifically 2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid. This compound has shown potential in modulating blood or serum uric acid levels. In various embodiments, it is utilized for the treatment or prevention of disorders associated with abnormal uric acid levels. The compound is particularly noted for its effectiveness in reducing serum uric acid levels in humans. Additionally, the patent describes formulations and methods of using these compounds for therapeutic purposes.
Career Highlights
Li-Tain Yeh is currently associated with Ardea Biosciences, Inc., where he continues to innovate in the field of pharmaceutical development. His work has been instrumental in advancing treatments that address uric acid-related disorders, showcasing his commitment to improving patient health outcomes.
Collaborations
Li-Tain Yeh has collaborated with notable colleagues, including Barry D. Quart and Jean-Luc Girardet, who contribute to the research and development efforts at Ardea Biosciences, Inc. Their combined expertise enhances the innovative capabilities of the team.
Conclusion
Li-Tain Yeh's contributions to the field of medicinal chemistry, particularly in the modulation of uric acid levels, highlight his role as a key inventor in this area. His ongoing work promises to lead to significant advancements in the treatment of related health disorders.